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Abstract

Introduction
Hypercalciuria is defined as a daily urinary excretion of calcium of more than 4 mg/kg body weight (BW)
( > 0 .1 mmol/kg BW) in either sex ( 11). It can be found
in nearly 50% of patients with idiopathic calcium nephrolithiasis and in about 5 % of normal people (11, 27).
Hypercalciuria is a familial trait (8) with characteristics
of autosomal dominant inheritance (24). Since hypercalciuric subjects produce urine which is abnormally supersaturated with respect to calcium oxalate (36), and since
lowering urinary calcium concentration by thiazide diuretics reduces the activity of nephrolithiasis (10, 38),
hypercalciuria can be considered as a risk factor for calcium oxalate crystallization and, subsequently, renal
stone formation (11). It has to be noted, however, that
for identical standard deviation increments in urinary
calcium and oxalate concentrations above the normal
means, the rise in urinary oxalate is much more critical
for calcium oxalate stone formation than that in urinary
calcium (33).
This article reviews idiopathic hypercalciuria, with
special emphasis on assessment of parathyroid function
as well as on the production of l ,25(OH)i-vitamin D 3
(calcitriol) in patients affected by this syndrome.

At the origin, idiopathic hypercalciuria has been
described as a syndrome consisting of normocalcemia,
low plasma phosphate levels and abnormally high urinary calcium excretion. The cause of this syndrome was
subject to many investigations throughout the years.
Two main pathophysiologic hypotheses have been proposed: a) primary intestinal hyperabsorption of calcium,
leading to depression of parathyroid hormone (PTH) secretion ("absorptive" hypercalciuria); and b) primary
renal tubular leak of calcium which stimulates PTH secretion (secondary hyperparathyroidism).
Most of the
published studies indicate that intestinal hyperabsorption
of calcium with subsequent relative hypoparathyroidism
is the primary event causing idiopathic hypercalciuria,
and that this occurs as a consequence of increased production of l ,25(OH)i-vitamin D 3 (calcitriol).
Fasting
hypercalciuria, originally taken as evidence for a "renal
leak" of calcium, appears to be, at least in part, the
consequence of relative hypoparathyroidism.

History of Idiopathic Hypercalciuria
Key Words: Calcium renal stone disease, idiopathic
hypercalciuria, absorptive/renal
hypercalciuria, parathyroid hormone, calcitriol.

In 1939, Flocks described 35 patients suffering
from calcium stones in kidneys or ureters and from
"slight infection" of the urinary tract (13). When these
patients were administered a diet with high calcium content (2500 mg/d), they clearly separated into two groups:
those (n = 12) whose urinary excretion of calcium remained normal or low ( < 300 mg/d), and those (n =
23) in whom it was elevated(> 420 mg/d), two of them
probably having hyperparathyroidism
(13). In 1953,
Albright et al. described a syndrome consisting of normocalcemia, low plasma phosphorus levels and hypercalciuria in 21 patients in whom the cause of hypercalciuria
was considered to be "not as yet clear" (1), e.g., no hyperparathyroidism, hyperthyroidism, progressing osteoporosis, high calcium intake, metastatic malignancy, myeloma, sarcoidosis, renal tubular acidosis, or vitamin D
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poisoning were present; the term "idiopathic hypercalciuria" (IH) was thus coined (I).
Five years later, Henneman et al. (16) essentially
described the same syndrome in 35 patients (including
the 21 cases originally studied by Albright et al.), in
comparison with 14 patients with "mild" hyperparathyroidism. Although an assessment of parathyroid function at this time was impossible "unless one has explored
the neck" (16), the following sequence of events leading
to IH was postulated: a tubular damage by (staphylococcal) pyelonephritis would result in decreased reabsorption of calcium, and thus, in hypercalciuria; subsequently, a tendency towards hypocalcemia would be followed
by compensatory hyperparathyroidism with consecutive
hyperphosphaturia and hypophosphatemia (1, 16). The
concept of "primary renal tubular hypercalciuria" was
thus born (16).
However, balance studies in four of Henneman' s
patients with IH revealed an abnormally low fecal calcium excretion (about half the normal value) which only
could be explained by increased intestinal calcium absorption, possibly due to "excessive vitamin D activity"
(16). Actually, studies performed in the sixties did demonstrate elevated intestinal absorption of calcium in patients with IH, compared with normal controls (3, 12,
23). Based on their calcium kinetic studies, Liberman
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et al. concluded "that the primary disturbance in idiopathic hypercalciuria is neither intestinal hyperabsorption nor urinary hyperexcretion of calcium, but both
these ... " (23), which perfectly anticipated forthcoming
studies on the pathophysiology of IH.
"Absorptive" versus "Renal" Hypercalciuria
In the early seventies, serum parathyroid hormone
(PTH) immunoassays became available. In 1973, Coe et
al. (7) reported that serum PTH levels, measured by a
radioimmunoassay which detected carboxy- as well as
amino-terminal PTH fragments, were elevated in 26 out
of 40 patients with IH; thus, a primary renal leak of
calcium with secondary hyperparathyroidism in the majority of cases with IH appeared as a reasonable hypothesis (7). The latter was further supported by studies in
4 normal volunteers to whom furosemide had been administered for 9 days: urinary calcium excretion had
risen, e.g., hypercalciuria had developed, and serum
PTH had increased to levels equivalent to those observed
in patients with IH (7).
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The dogma of a primary renal leak of calcium in
IH was challenged one year later (30): based on measurements of PTH (using an antiserum mainly recognizing
the amino-terminal portion of the PTH molecule) and of
urinary cAMP as well as fractional absorption of calcium from the intestinal tract (orally administered 47 Ca) in
patients with calcium nephrolithiasis on a low calcium
diet (400 mg/d), Pak et al. (30) demonstrated that primary intestinal hyperabsorption of calcium was the
backbone of the IH syndrome in 22 out of 30 stone formers; they thought, however, that both "absorptive" and
"renal" hypercalciuria might be found as distinct entities
in patients with IH and calcium renal stones.
Based on the observed correlation between fractional intestinal calcium absorption and calciuric response after oral calcium loading (1 g of calcium), Pak
et al. subsequently developed a simple test for ambulatory evaluation of the causes of hypercalciuria (31); patients with normocalcemia, normal fasting and high urinary calcium after calcium loading were called "absorptive" hypercalciurics, whereas those with normocalcemia, high fasting urinary calcium and .high fasting urinary cAMP were called "renal" hypercalciurics.
In the
latter group, however, a poor correlation was found between fractional intestinal absorption of calcium and calciuric response after oral calcium loading (40). Furthermore, when routinely applied to the clinical evaluation
of patients with IH and calcium nephrolithiasis, the oral
calcium loading test appeared to be of limited value,
since either more than 50% of the patients could not be
classified as "absorptive" or "renal" hypercalciurics
(20), or the values largely overlapped in IH and in
normals (22).
When carefully considering the regulatory feedback mechanisms (11) that occur as a consequence of either a primary intestinal hyperabsorption of calcium
("absorptive" hypercalciuria, Figure 1) or a primary
renal leak of calcium ("renal" hypercalciuria, Figure 2),
one realizes that, once steady-state conditions have been
reached, both sequences of events predict increased intestinal absorption and decreased renal tubular reabsorption of calcium (11).

former. Indeed, as summarized in Table 1, numerous
studies have clearly demonstrated increased or high-normal, but neither decreased nor low-normal serum levels
of calcitriol in IH, irrespective of its "absorptive" or
"renal" origin (2, 5, 15, 19, 34, 39); in other studies,
serum calcitriol was at least up-regulated in the face of
the status of its modulators, namely blood ionized calcium (9), phosphate (2) and PTH (9) concentrations.
This points to a disturbed control of calcitriol synthesis (2, 11, 18) in patients with IH, with subsequent depression of PTH synthesis. Alternatively, one may envision increased sensitivity of the intestine and/or the
parathyroid glands to calcitriol.
Indeed, Silver et al.
(35) have demonstrated that calcitriol decreases the
transcription of the PTH gene and, subsequently, lowers
PTH synthesis.

Parathyroid Function in Patients with IH
As postulated by Coe and Bushinsky (11), a primary increase in calcitriol synthesis would lead to low
or low-normal PTH values in steady-state measurements,
whereas a primary renal leak of calcium would tend to
raise serum PTH values (secondary hyperparathyroidism). However, with exception of the original article by
Coe et al. (7), as well as in part of the reports by Pak et
al. (30), Bordier et al. (4) and Pak and Galosy (32),
none of the published studies (2, 5, 6, 9, 15, 25, 28)
ever confirmed the existence of secondary hyperparathyroidism in patients with IH. On the contrary, the vast
majority of published data indicates normal (2, 6, 28) or
even decreased (5, 9, 15, 25, 34) fasting blood levels of
PTH levels in patients with IH, compared with healthy
controls (Table 2). Recently, using a sensitive immunoradiometric assay to detect the intact PTH molecule, we
confirmed the occurrence of relative hypoparathyroidism in male hypercalciurics with recurrent idiopathic
calcium nephrolithiasis in comparison with normocalciuric calcium renal stone formers; furthermore, urinary
excretion rates of urea and sulfate, markers of protein
consumption, were significantly higher in hypercalciuric
stone formers (17). It remains to be seen to what extent
increased protein consumption, a known dietary risk factor for idiopathic hypercalciuria (14), may be related to
the up-regulation of calcitriol and the subsequent relative
hypoparathyroidism that can be observed in hypercalciuric calcium renal stone formers (17).

Intestinal Absorption of Calcium in Patients with IH
Since elevated intestinal absorption of calcium appears to occur in "absorptive" as well as in "renal" hypercalciuria (Figures 1 and 2), it is not surprising that
comparative studies carried out in patients with IH and
in normal controls unequivocally found such increased
fractional intestinal absorption of calcium in IH (3, 12,
19, 23, 29, 30, 34, 37), irrespective whether (19, 29,
30) or not (3, 12, 23, 34, 37) patients were subdivided
into "absorptive" and "renal" hypercalciurics.
From a theoretical standpoint, at that time, intestinal hyperabsorption of calcium could have been envisioned as calcitriol-dependent or calcitriol-independent.
Over the years, however, refinement of calcitriol assays
allowed to obtain substantial evidence in favor of the

Fasting Hypercalciuria
Fasting hypercalciuria has been thought to indicate a primary renal tubular leak of calcium (31). However, it could equally well be the consequence of relative
hypoparathyroidism in IH. As demonstrated by Broadus
et al. (5), there is a significant negative correlation between fasting urinary calcium excretion and parathyroid
function, based on measurements of urinary cyclic AMP,
a phenomenon that the intact PTH assay helped us to
confirm (17). Thus, the ever-observed renal leak of calcium in some patients with IH could just have an hormonal basis (5).
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Table 1. Plasma calcitriol in patients with hypercalciuria (HC) and calcium nephrolithiasis.
Mean plasma calcitriol t Ref.No.

Type of HC

n

IH

26

+

IH

15

+

72

15

59

34

"AH"
"RH"

21
3

+
+

32
103

19

"AH"
"RH"

11
10

+
+

113
53

9

IH

24

+

18

9

"AH"

50

+

64

5

IH

42

+

38

2

IH
"AH"
"RH"
n

t
Ref. No.

Table 2. Serum PTH in patients with hypercalciuria
(HC) and calcium nephrolithiasis.

idiopathic hypercalciuria;
absorptive hypercalciuria;
renal hypercalciuria.
number of patients;
% deviation from mean of controls
Reference number.

n

1H

40

+

55•

7

"AH"
"RH"

22
2

-

33
198

30

+

"RH"

9

+

30•

4

1H

26

-

3

15

1H

15

- 33

34

"AH"

51
20

- 47
172

32

"RH"

+

1H

41

- 41

25

1H

24

- 28

9

"AH"
RH

15
21

-

60*
- 54•

28

1H

42

-

11

11

In addition, dietary NaCl intake appears to be a
determinant not only of daily, but also of fasting hypercalciuria. Indeed, an increase in dietary NaCl consumption lowers calcium reabsorption along the renal tubule
(14), thus inducing with some time lag fasting hypercalciuria (21, 26). Since not all patients with recurrent
calcium nephrolithiasis seem to consume NaCl in excess
(14), undue sensitivity to the calciuric stimulus of NaCl
has been postulated in these patients (14, 21).

Mean plasma calcitriol t Ref.No.

Type of HC

16

2

For abbreviation definitions, see Table 1.
• = % deviation from indicated upper limit of normal
range of PTH values (no healthy controls studied).

t Calcitriol

Summary

I

t sens. to calcitriol

Altogether, available data strongly suggest that
the syndrome of IH includes features of both intestinal
hyperabsorption and reduced renal tubular reabsorption
of calcium (9, 23). There seems to be convincing evidence, however, for a primary increase in calcitriol production in patients with IH; alternatively, increased sensitivity of the intestine and/or the parathyroid glands to
normal calcitriol levels might be present in some patients
with IH. Both will depress PTH synthesis and induce
relative hypoparathyroidism.
The latter directly contributes to hypercalciuria, i.e., the lower PTH secretion, the
higher urinary calcium excretion (Figure 3). A substantial body of evidence supports the view that "absorptive"
and "renal" hypercalciuria are not distinctive entities,
but rather two extremes of a continuum behavior (9):
"absorptive" hypercalciuria will be found in patients in
whom a night of fast suffices to finalize calcium absorption and elimination and to return PTH secretion to normal, whereas "renal" hypercalciuria will be found in
those patients whose PTH suppression and ensuing renal

t intest.

◊
Ca absorption

◊

t Ca++
◊

! PTH
◊

t Uca XV
Figure 3. Sequence of events leading to hypercalciuria.
Uca x V = 24-hour urine excretion of calcium.
For
other abbreviations, see Fig. 1.
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leakage of calcium last longer. Whether a particular
patient is an "absorptive" or "renal" (fasting) hypercalciuric probably depends, at least in part, also on dietary
factors, such as NaCl consumption.

Kidney Int. 34: 544-555.
15. Gray RW, Wilz DR, Caldas AE, Lemann J Jr
(1977). The importance of phosphate in regulating plasma 1,25-(OH)i-vitamin D levels in humans: studies in
healthy subjects, in calcium-stone formers and in patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 45: 299-306.
16. Henneman Ph, Benedict PH, Forbes AP,
Dudley HR (1958). Idiopathic hypercalcuria. N. Engl.
J. Med. 259: 802-807.
17. Hess B, Casez J-P, Takkinen R, Ackermann
D, Jaeger Ph (1993). Relative hypoparathyroidism and
calcitriol up-regulation in hypercalciuric calcium renal
stone formers. Am. J. Nephrol. (in press).
18. Insogna KL, Broadus AE, Drever BE, Ellison
AF, Gertner JM (1985). Elevated production rate for
1,25 dihydroxyvitamin Din patients with absorptive hypercalciuria. J. Clin. Endocrinol. Metab. 61: 490-495.
19. Kaplan RA, Haussler MR, Deftos LJ, Bone
H, Pak CYC (1977). The role of 1-alpha,25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption
of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J. Clin. Invest. 59: 756-760.
20. Kraiem Z, Schotland Y, Bernheim J, Embon
0, Lurie A, Sheinfeld M, Gonda M (1983). Assessment
of the calcium loading test in differentiation between
various forms of idiopathic hypercalciuria. Isr. J. Med.
Sci. 19: 596-599.
21. Lau YK, Wasserstein AG, Westby GR,
Bosanac P, Grabie M, Mitnick P, Slatopolsky E,
Goldfarb S, Agus ZS (1982). Proximal tubular defects in
idiopathic hypercalciuria: resistance to phosphate administration. Mineral Electrolyte Metab. 7: 237-249.
22. Lein JW, Keane PM (1983). Limitations of
the oral calcium loading test in the management of the
recurrent calcareous renal stone former. Am. J. Kid.
Dis. 1: 76-79.
23. Liberman UA, Sperling 0, Atsmon A, Frank
M, Modan M, DeVries A (1968). Metabolic and calcium
kinetic studies in idiopathic hypercalciuria. J. Clin.
Invest. 47: 2580-2590.
24. Mehes K, Szelid Z (1980). Autosomal dominant inheritance of hypercalciuria. Eur. J. Pediatr. 133:
239-242.
25. Muldowney FP, Freaney R, Ryan JG (1980).
The pathogenesis of idiopathic hypercalciuria: evidence
for renal tubular calcium leak. Quart. J. Med. 49: 8794.
26. Muldowney FP, Freaney R, Moloney MF
(1982). Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int. 22: 292-296.
27. Nordin BEC, Hodgkinson A, Peacock M
(1967). The measurement and the meaning of urinary
calcium. Clin. Orthop. 52: 293-322.
28. Olmer M, Berland Y, Argemi B (1983). Absence of secondary hyperparathyroidism in most patients
with renal hypercalciuria. Kidney Int. 24: S175-S179.
29. Pak CYC, East DA, Sanzenbacher LJ, Delea
CS, Bartter FC (1972). Gastrointestinal calcium absorp-

Acknowledgement

This work was supported in part by the Swiss
National Science Foundation (Grant No. 32-33543-92).
References
1. Albright F, Henneman Ph, Benedict PH,
Forbes AP (1953), Idiopathic hypercalciuria (a preliminary report). Proc. Roy. Soc. Med. 46: 1077-1081.
2. Bataille P, Achard JM, Fournier A and 11
other authors (1991). Diet, vitamin D and vertebral
mineral density in hypercalciuric calcium stone formers.
Kidney Int. 39: 1193-1205.
3. Birge SJ, Peck WA, Berman M, Whedon GD
(1969). Study of calcium absorption in man: a kinetic
analysis and physiologic model. J. Clin. Invest. 48:
1705-1713.
4. Bordier Ph, Ryckewart A, Gueris J, Rasmussen
H (1977). On the pathogenesis of so-called idiopathic
hypercalciuria. Am. J. Med. 63: 398-409.
5. Broadus AE, Insogna KL, Lang R, Mallette
LE, Oren DA, Gertner JM, Kliger AS, Ellison AF
(1984). A consideration of the hormonal basis and phosphate leak hypothesis of absorptive hypercalciuria. J.
Clin. Endocrinol. Metab. 58: 161-169.
6. Burckhardt P, Jaeger Ph. (1981). Secondary
hyperparathyroidism in idiopathic renal hypercalciuria:
fact or theory? J. Clin. Endocrinol. Metab. 53: 550-555.
7. Coe FL, Canterbury JM, Firpo JJ, Reiss E
(1973). Evidence for secondary hyperparathyroidism in
idiopathic hypercalciuria. J. Clin. Invest. 52: 134-142.
8. Coe FL, Parks JH, Moore ES (1979). Familial
idiopathic hypercalciuria. N. Engl. J. Med. 300: 337340.
9. Coe FL, Favus MJ, Crockett T, Strauss AL,
Parks JH, Pcrat A, Gantt CL, Sherwood LM (1982). Effects of low-calcium diet in urine calcium excretion, parathyroid function and serum l ,25(OH)iD 3 levels in patients with idiopathic hypercalciuria and in normal
subjects. Am. J. Med. 72: 25-32.
10. Coe FL (1983). Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 24: 392-403.
11. Coe FL, Bushinsky D (1984). Pathophysiology of hypercalciuria. Am. J. Physiol. 247 (Renal Fluid
Electrolyte Physiol. 16): Fl-F13.
12. Edwards NA, Hodgkinson A (1965). Metabolic studies in patients with idiopathic hypercalciuria.
Clin. Sci. 29: 143-157.
13. Flocks RH (1939). Calcium and phosphorus
excretion in the urine of patients with renal or ureteral
calculi. JAMA 113: 1466-1471.
14. Goldfarb S (1988). Dietary factors in the
pathogenesis and prophylaxis of calcium nephrolithiasis.

407

B. Hess and Ph. Jaeger
tion in nephrolithiasis. J. Clin. Endocrinol. Metab. 35:
261-270.
30. Pak CYC, Ohata M, Lawrence EC, Snyder W
(1974). The hypercalciurias: causes, parathyroid functions, and diagnostic criteria. J. Clin. Invest. 54: 387400.
31. Pak CYC, Kaplan R, Bone H, Townsend J,
Waters O (1975). A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N. Engl.
J. Med. 292: 497-500.
32. Pak CYC, Galosy RA (1979). Fasting urinary
calcium and adenosine 3' ,5 '-monophosphate: a discriminant analysis for the identification of renal and absorptive hypercalciurias. J. Clin. Endocrinol. Metab. 48:
260-265.
33. Robertson WO, Peacock M, Heyburn PJ,
Marshall DH, Clark PB (1978). Risk factors in calcium
stone disease of the urinary tract. Br. J. Urol. 50: 449454.
34. Shen FH, Baylink DJ, Nielsen RL, Sherrard
DJ, Ivey JL, Haussler MR (1977). Increased serum
1,25-dihydroxyvitamin Din idiopathic hypercalciuria. J.
Lab. Clin. Med. 90: 955-962.
35. Silver J, Russell J, Sherwood LM (1985).
Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J. Clin.
Invest. 78: 1296-1301.
36. Weber DV, Coe FL, Parks JH, Dun SL,
Tembe V (1979). Urinary saturation measurements in
calcium nephrolithiasis. Ann.Int. Med. 90: 180-184.
37. Wills MR, Zisman E, Wortsman J, Evens RG,
Pak CYC, Bartter FC (1970). The measurement of intestinal calcium absorption by external radioisotope counting: application to study of nephrolithiasis. Clin. Sci.
39: 95-106.
38. Yendt ER, Cohanim M (1978). Prevention of
calcium stones with thiazides. Kidney Int. 13: 397-409.
39. Zerwekh JE, Pak CYC (1980). Selective effects of thiazide therapy on serum l-alpha,25-dihydroxyvitamin D and intestinal calcium absorption in renal and
absorptive hypercalciurias. Metabolism 29: 13-17.
40. Zerwekh JE, Sakhaee K, Pak CYC (1981).
Utility and limitation of calciuric response to oral calcium load as a measure of intestinal calcium absorption:
comparison with isotopic fractional calcium absorption.
Invest. Urol. 19: 161-164.

Editor's Note: All of the reviewer's concerns were appropriately addressed by text changes, hence there is no
Discussion with Reviewers.

408

